Login / Signup

Reporting Hormone Receptor Expression in Breast Carcinomas: Which Method has the Highest Prognostic Power and What Should be the Optimal Cut-off Value?

Çiğdem ÖztürkOğuzhan OkcuSeda Duman ÖztürkBayram ŞenAhmet Emin ÖztürkRecep Bedir
Published in: International journal of surgical pathology (2024)
All recommended methods for reporting HRs have similar prognostic power. However, in patients with high percentage staining for ER using these methods, the prognosis is excellent. As a result, we predict that if the percentage of ER staining is low, changing the treatment management of patients may be considered clinically.
Keyphrases
  • adverse drug
  • poor prognosis
  • endoplasmic reticulum
  • estrogen receptor
  • breast cancer cells
  • flow cytometry
  • emergency department
  • combination therapy
  • replacement therapy